Susquehanna Fundamental Investments LLC Invests $782,000 in Simulations Plus, Inc. (NASDAQ:SLP)

Susquehanna Fundamental Investments LLC purchased a new position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 28,028 shares of the technology company's stock, valued at approximately $782,000. Susquehanna Fundamental Investments LLC owned 0.14% of Simulations Plus as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the company. Hsbc Holdings PLC bought a new position in Simulations Plus in the 4th quarter worth about $593,000. State of Tennessee Department of Treasury boosted its position in shares of Simulations Plus by 21.0% in the fourth quarter. State of Tennessee Department of Treasury now owns 11,813 shares of the technology company's stock valued at $329,000 after acquiring an additional 2,052 shares during the period. Tower Research Capital LLC TRC grew its stake in Simulations Plus by 42.2% during the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after acquiring an additional 764 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in Simulations Plus by 6.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 419,241 shares of the technology company's stock worth $11,693,000 after acquiring an additional 24,266 shares during the period. Finally, First Trust Advisors LP lifted its stake in Simulations Plus by 47.3% in the 4th quarter. First Trust Advisors LP now owns 9,393 shares of the technology company's stock worth $262,000 after purchasing an additional 3,015 shares in the last quarter. Hedge funds and other institutional investors own 78.08% of the company's stock.

Wall Street Analysts Forecast Growth

SLP has been the subject of several research analyst reports. William Blair reissued an "outperform" rating on shares of Simulations Plus in a research note on Wednesday, January 8th. StockNews.com upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. Finally, KeyCorp lifted their target price on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $50.00.

Insider Buying and Selling at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. This trade represents a 0.59 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 19.40% of the company's stock.

Simulations Plus Price Performance

NASDAQ SLP traded down $0.56 on Wednesday, reaching $28.45. 229,471 shares of the company's stock traded hands, compared to its average volume of 205,997. The stock has a market cap of $572.16 million, a PE ratio of 70.58 and a beta of 1.10. Simulations Plus, Inc. has a 12 month low of $23.01 and a 12 month high of $51.22. The stock has a 50-day simple moving average of $28.70 and a 200 day simple moving average of $30.33.

Simulations Plus (NASDAQ:SLP - Get Free Report) last issued its earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same quarter last year, the company earned $0.20 EPS. The firm's revenue was up 22.5% compared to the same quarter last year. As a group, analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.